A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clinical Sciences & Operations
Sanofi
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California at San Francisco
San Francisco, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- University of Chicago
Chicago, Illinois, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of North Carolina-Ch Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 31 Oct 2012
- Completion
- 31 Jul 2013
- Last update posted
- 17 Mar 2016
- Registered enrollment
- 44
- Registry id
- NCT01173497
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.